T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.07% |
| 2 | Healthcare | 18.73% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.39% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ELAT
1351
DELISTED
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
ELAT
| – | – |
-125,242
| Closed | -$3.58M |
|
1352
Guidewire Software
GWRE
$15.2B
| $2.6M | ﹤0.01% |
42,255
+4,937
| +13% | +$357K |
|
1353
Maximus
MMS
$2.94B
| $2.6M | ﹤0.01% |
44,958
-53,633
| -54% | -$3.34M |
|
1354
Valvoline
VVV
$4.25B
| $2.6M | ﹤0.01% |
102,671
-8,638
| -8% | -$253K |
|
1355
Prestige Consumer Healthcare
PBH
$2.43B
| $2.6M | ﹤0.01% |
52,172
+5,480
| +12% | +$303K |
|
1356
KBR
KBR
$4.81B
| $2.6M | ﹤0.01% |
60,048
+11,907
| +25% | +$586K |
|
1357
National Grid
NGG
$81.6B
| $2.6M | ﹤0.01% |
+53,546
| New | +$3.22M |
|
1358
Erie Indemnity
ERIE
$13.5B
| $2.59M | ﹤0.01% |
11,637
+1,761
| +18% | +$371K |
|
|
SMAR
1359
DELISTED
Smartsheet Inc.
SMAR
| $2.58M | ﹤0.01% |
75,053
+1,905
| +3% | +$64.5K |
|
1360
Agree Realty
ADC
$9.25B
| $2.58M | ﹤0.01% |
38,119
+7,144
| +23% | +$537K |
|
1361
ManpowerGroup
MAN
$2.75B
| $2.58M | ﹤0.01% |
39,792
-2,741
| -6% | -$206K |
|
1362
Gentherm
THRM
$1.27B
| $2.57M | ﹤0.01% |
51,733
-939,404
| -95% | -$56.9M |
|
1363
Black Hills Corp
BKH
$5.64B
| $2.56M | ﹤0.01% |
37,786
+6,105
| +19% | +$458K |
|
1364
Visteon
VC
$2.86B
| $2.54M | ﹤0.01% |
23,918
-535,763
| -96% | -$63.9M |
|
1365
Privia Health
PRVA
$2.78B
| $2.54M | ﹤0.01% |
74,438
-2,705,766
| -97% | -$100M |
|
1366
Edgewise Therapeutics
EWTX
$4.69B
| $2.52M | ﹤0.01% |
256,238
-92,985
| -27% | -$940K |
|
1367
SOPHiA GENETICS
SOPH
$649M
| $2.51M | ﹤0.01% |
955,506
-985,776
| -51% | -$3.45M |
|
1368
Crane NXT
CXT
$2.96B
| $2.51M | ﹤0.01% |
82,538
+7,540
| +10% | +$249K |
|
1369
iShares Russell 2000 ETF
IWM
$82.4B
| $2.5M | ﹤0.01% |
15,156
+1,857
| +14% | +$339K |
|
1370
SEI Investments
SEIC
$12.7B
| $2.49M | ﹤0.01% |
50,804
-2,922
| -5% | -$160K |
|
|
UMPQ
1371
DELISTED
Umpqua Holdings Corp
UMPQ
| $2.46M | ﹤0.01% |
143,701
+22,643
| +19% | +$402K |
|
1372
Western Union
WU
$2.34B
| $2.45M | ﹤0.01% |
181,394
-11,398
| -6% | -$179K |
|
1373
Saic
SAIC
$5.35B
| $2.45M | ﹤0.01% |
27,652
+6,016
| +28% | +$560K |
|
|
LSXMK
1374
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $2.44M | ﹤0.01% |
83,595
+16,566
| +25% | +$515K |
|
1375
Immatics
IMTX
$1.33B
| $2.44M | ﹤0.01% |
+243,694
| New | +$2.63M |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.